|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2022 | Cognitive improvements accompanied with WPAI improvements in OCR-treated patients with RRMS: 96-week CASTING data | Vermersch, P.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Benedict, R. | Journal Contribution | M |
| 2 | 2022 | Safety of Alemtuzumab in Patients with Multiple Sclerosis: Interim Results of a Post-Authorization Safety Study (PASS) | Montalban, X.; VAN WIJMEERSCH, Bart; Gobbi, C.; Robertson, N.; Klotz, L.; Achiron, A.; Lee, A.; Eichau, S.; Vecsei, L.; Benzerdjeb, H.; Rodrigues, A.; Jurgensen, S.; Chirieac, M.; Comi, G. | Journal Contribution | M |
| 3 | 2022 | Confirmed disability progression as a marker of permanent disability in multiple sclerosis | Sharmin, Sifat; Bovis, Francesca; Malpas, Charles; Horakova, Dana; Havrdova, Eva Kubala; Izquierdo, Guillermo; Eichau, Sara; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Onofrj, Marco; Lugaresi, Alessandra; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Terzi, Murat; Gerlach, Oliver; Alroughani, Raed; Boz, Cavit; Shaygannejad, Vahid; van Pesch, Vincent; Cartechini, Elisabetta; Kappos, Ludwig; Lechner-Scott, Jeannette; Bergamaschi, Roberto; Turkoglu, Recai; Solaro, Claudio; Iuliano, Gerardo; Granella, Franco; VAN WIJMEERSCH, Bart; Spitaleri, Daniele; Slee, Mark; McCombe, Pamela; Prevost, Julie; Ampapa, Radek; Ozakbas, Serkan; Sanchez-Menoyo, Jose Luis; Soysal, Aysun; Vucic, Steve; Petersen, Thor; de Gans, Koen; Butler, Ernest; Hodgkinson, Suzanne; Sidhom, Youssef; Gouider, Riadh; Cristiano, Edgardo; Castillo-Trivino, Tamara; Saladino, Maria Laura; Barnett, Michael; Moore, Fraser; Rozsa, Csilla; Yamout, Bassem; Skibina, Olga; van der Walt, Anneke; Buzzard, Katherine; Gray, Orla; Hughes, Stella; Sempere, Angel Perez; Singhal, Bhim; Fragoso, Yara; Shaw, Cameron; Kermode, Allan; Taylor, Bruce; Simo, Magdolna; Shuey, Neil; Al-Harbi, Talal; Macdonell, Richard; Dominguez, Jose Andres; Csepany, Tunde; Sirbu, Carmen Adella; Sormani, Maria Pia; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 4 | 2022 | Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis | Lefort, M.; Sharmin , S.; Andersen, J. B.; Vukusic, S.; Casey, R.; Debouverie, M.; Edan, G.; Ciron, J.; Ruet, A.; De Seze, J.; Maillart, E.; Zephir, H.; Labauge, P.; Defer, G.; Lebrun-Frenay, C.; Moreau, T.; Berger , E.; Clavelou, P.; Pelletier, J.; Stankoff, B.; Gout, O.; Thouvenot, E.; Heinzlef, O.; Al-Khedr, A.; Bourre, B.; Casez, O.; Cabre, P.; Montcuquet, A.; Wahab, A.; Camdessanche, J. P.; Maurousset, A.; Ben Nasr, H.; Hankiewicz, K.; Pottier, C.; Maubeuge, N.; Nifle, C.; Laplaud, D. A.; Horakova, D.; Dimitri-Boulos, D.; Havrdova, E. K.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Ozakbas, S.; Patti, F.; Onofrj, M.; Lugaresi, A.; Terzi, M.; Grammond, P.; Grand'Maison, F.; Yamout, B.; Prat, A.; Girard, M.; Duquette, P.; Boz, C.; Trojano, M.; McCombe, P.; Slee, M.; Lechner-Scott, J.; Turkoglu, R.; Sola, P.; Ferraro, D.; Granella, F.; Shaygannejad, V; Prevost, J.; Maimone, D.; Skibina, O.; Buzzard, K.; Van der Walt, A.; Karabudak, R.; VAN WIJMEERSCH, Bart; Csepany, T.; Spitaleri, D.; Vucic, S.; Koch-Henriksen, N.; Sellebjerg, F.; Soerensen , P. S.; Christensen, C. C. Hilt; Rasmussen, P., V; Jensen, M. B.; Frederiksen, J. L.; Bramow, S.; Mathiesen, H. K.; Schreiber, K., I; Butzkueven, H.; Magyari, M.; Kalincik, T.; Leray, E. | Journal Contribution | A1 |
| 5 | 2022 | Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset | YPERMAN, Jan; POPESCU, Veronica; VAN WIJMEERSCH, Bart; BECKER, Thijs; PEETERS, Liesbet | Journal Contribution | A1 |
| 6 | 2022 | Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180] | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva Kubala; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'Maison, Francois; VAN WIJMEERSCH, Bart; Bergamaschi, Roberto; Sá, Maria José; Soysal, Aysun; Sanchez-Menoyo, Jose Luis; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara Castillo; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 7 | 2022 | Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide | VAN WIJMEERSCH, Bart; Hartung, Hans-Peter; Vermersch, Patrick; Pugliatti, Maura; Pozzilli, Carlo; Grigoriadis, Nikolaos; Alkhawajah, Mona; Airas, Laura; Linker, Ralf; Oreja-Guevara, Celia | Journal Contribution | A1 |
| 8 | 2022 | A multi-stakeholder survey on multiple sclerosis multidisciplinary care: The situation in Belgium and lessons for the global community | Van Hijfte, L.; Cambron, M.; Capron, B.; Dachy, B.; Decoo, D.; Dive, D.; Dubois, B.; El Sankari, S.; London, F.; Perrotta, G.; POPESCU, Veronica; Van Pesch, V.; VAN WIJMEERSCH, Bart; Willekens, B.; Laureys, G. | Journal Contribution | M |
| 9 | 2022 | Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis | Daruwalla, C.; Shaygannejad, V.; Ozakbas, S.; Havrdova, E. K.; Alroughani, R.; Patti, F.; Onofrj, M.; Eichau, S.; Girard, M.; Grand'Maison, F.; Yamout, B.; Sajedi, S. A.; Amato, M. P.; Altintas, A.; Skibina, O.; Grammond, P.; Butzkueven, H.; Maimone, D.; Lechner-Scott, J.; Soysal, A.; John, N.; Gerlach, O.; Iuliano, G.; Foschi, M.; Van Pesch, V.; Cartechini, E.; Kuhle, J.; Sa, M. J.; Kermode, A.; Gouider, R.; Hodgkinson, S.; McCombe, P.; Sanchez-Menoyo, J. L.; Singhal, B.; Blanco, Y.; Hughes, S.; McGuigan, C.; Taylor, B.; Habek, M.; Al-Asmi, A.; Mihaela, S.; Castillo Trivino, T.; Al-Harbi, T.; Rojas, J. I.; Gray, O.; Khurana, D.; VAN WIJMEERSCH, Bart; Coles, A.; Kalincik, T.; Brown, J. W. L. | Journal Contribution | M |
| 10 | 2022 | Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 11 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS | Kalincik, T.; Sharman, S.; Roos, I.; Freedman, M.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A.; Horakova, D.; Havrdova, E.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; McCombe, P.; VAN WIJMEERSCH, Bart; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Ozakbas, S.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Boz, C.; Kuhle, J.; Patti, F.; Terzi, M.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Onofrj, M.; Lugaresi, A.; Khoury, S.; Soysal, A.; Slee, M.; Prevost, J.; Turkoglu, R.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 12 | 2022 | Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation | Zhu, C.; Kalincik, T.; Horakova, D.; Zhen, Z.; Buzzard, K.; Skibina, O.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Kuhle, J.; Patti, F.; Grand'Maison, F.; Hodgkinson, S.; Grammond, P.; Lechner-Scott, J.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Macdonell, R.; Weinstock-Guttman, B.; Ozakbas, S.; Slee, M.; Sa, M. Jose; Van Pesch, V.; Barnett, M.; VAN WIJMEERSCH, Bart; Gerlach, O.; Prevost, J.; Terzi, M.; Boz, C.; Laureys, G.; Van Hijfte, L.; Kermode, A.; Garber, J.; Yamout, B.; Khoury, S. J.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A.; Butzkueven, H. | Journal Contribution | M |
| 13 | 2022 | Efficacy and safety of ocrelizumab is maintained in patients with RRMS with suboptimal response to prior disease-modifying therapies: 4-year NEDA data from CASTING-LIBERTO | Oreja-Guevara, C.; Benedict, R. H.; Comi, G.; Cutter, G.; Kister, I.; Siva, A.; Wiendl, H.; VAN WIJMEERSCH, Bart; Wuerfel, J.; El Azzouzi, B.; Buffels, R.; Dirks, P.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 14 | 2022 | Employment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Wiendl, H.; Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 15 | 2022 | Walking fatigability manifests globally in several gait domains in people with multiple sclerosis during a prolonged walking | BALISTIERI SANTINELLI, Felipe; RAMARI FERREIRA, Cintia; GYSEMBERG, Griet; VAN WIJMEERSCH, Bart; Kos, D.; MEYNS, Pieter; FEYS, Peter | Journal Contribution | M |
| 16 | 2022 | A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis | AERTS, Sofie; KHAN, Hamza; SEVERIJNS, Deborah; POPESCU, Veronica; PEETERS, Liesbet; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 17 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS | Kalincik, T.; Sharmin , S.; Roos, I.; Freedman, M. S.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A. K.; Horakova, D.; Havrdova, E. K.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; VAN WIJMEERSCH, Bart; McCombe, P.; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Izquierdo, G.; Eichau, S.; Patti, F.; Hodgkinson, S.; Prevost, J.; Onofrj, M.; Lugaresi, A.; Alroughani, R.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Grand'Maison, F.; Laureys, G.; Van Hijfte, L.; Maimone, D.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 18 | 2021 | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | VAN WIJMEERSCH, Bart; Comi, G.; Oreja-Guevara, C.; Wiendl, H.; Wuerfel, J.; Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K.; Vermersch, P. | Journal Contribution | M |
| 19 | 2021 | Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data | Dayan, Colin; Lecumberri, Beatriz; Muller, Ilaria; Ganesananthan, Sashiananthan; Hunter, Samuel F.; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Havrdova, Eva K.; LaGanke, Christopher C.; Ziemssen, Tjalf; VAN WIJMEERSCH, Bart; Meuth, Sven G.; Margolin, David H.; Afsar, Salman; Daizadeh, Nadia; Poole, Elizabeth M.; Baker, Darren P.; Senior, Peter A. | Journal Contribution | M |
| 20 | 2021 | Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score | Kunchok, Amy; Lechner-Scott, Jeannette; Granella, Franco; Trojano, Maria; Alroughani, Raed; Sola, Patrizia; Ferraro, Diana; Lugaresi, Alessandra; Onofrj, Marco; Ozakbas, Serkan; Izquierdo, Guillermo; Grammond, Pierre; Luis Sanchez-Menoyo, Jose; VAN WIJMEERSCH, Bart; Boz, Cavit; Pucci, Eugenio; McCombe, Pamela; Grand'Maison, Francois; Spitaleri, Daniele; Vucic, Steve; Hupperts, Raymond; Jokubaitis, Vilija; Sormani, Maria Pia; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
Loading...
5
0
5
0
false